Menu

Eli Lilly

Eli Lilly and Company and Boehringer Ingelheim announce new drug application filing in the U.S. for new insulin glargine product

, , , , ,

New Drug Application follows submission of Marketing Authorisation Application to the European Medicines Agency INDIANAPOLIS and RIDGEFIELD, Conn., Dec. 20, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) for LY2963016, an […]

Lilly Diabetes/Disney Custom Books for Type 1 Diabetes Families Now Available Online

, , , ,

New resources housed on T1EverydayMagic.com combine the expertise of Lilly Diabetes with the magic of Disney INDIANAPOLIS, Dec. 19, 2013 /PRNewswire/ — Lilly Diabetes and Disney today announced that their custom books for children and families with type 1 diabetes are now available online. The digital books explore real-life challenges and stories of children with […]

Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On Therapy for Major Depressive Disorder

, , , ,

INDIANAPOLIS, Dec. 5, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that results from three studies of edivoxetine did not meet the primary study objective of superior efficacy in depression after eight weeks of treatment. When added to a selective serotonin reuptake inhibitor (SSRI), edivoxetine did not separate from placebo on the […]

Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation

, , , , ,

More than 10,000 people with self-reported and diagnosed type 2 diabetes and more than 6,500 treating-physicians from 26 countries to take part in new survey RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 2, 2013 /PRNewswire/ — Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the launch of the largest multinational survey to investigate early […]

Lilly Diabetes Extends National Sponsorship of the American Diabetes Association’s Signature Tour de Cure® Cycling Event for a Second Year

, , , ,

New sponsorship of “Red Riders®”–cyclists with diabetes–added in 5 cities INDIANAPOLIS, Nov. 19, 2013 /PRNewswire/ — News Highlights: For a 2nd year, #Lilly #Diabetes supports the American Diabetes Association’s Tour de Cure cycling event to help #StopDiabetes New in 2014, #Lilly #Diabetes to support #RedRider cyclists with #diabetes in 5 cities Lilly Tour de Cure […]

Alliance showcases shared commitment to type 1 diabetes community; kicks off activities for T1Day observance Nov. 1

, , , ,

MINNEAPOLIS and NEW YORK and INDIANAPOLIS, Nov. 1, 2013 /PRNewswire/ — News Highlights: Medtronic and Lilly Diabetes become first ever national presenting sponsors of the #JDRF Walk to Cure #Diabetes Medtronic, Lilly Diabetes help fund more than $500K for #T1D research through #JDRF Walk to Cure #Diabetes national sponsorship Medtronic, Lilly Diabetes’ #JDRF Walk to Cure #Diabetes national sponsorship announcement kicks off #T1Day […]

FDA Approves Addition to CIALIS® (tadalafil) Product Label

, , ,

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct. 25, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a product label addition for CIALIS to include data from a 26-week study that showed […]

FDA Grants Lilly’s Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer

, , , ,

INDIANAPOLIS, Oct. 23, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy. “We are very pleased that the FDA has […]

1 2 3